bioRxivPharmacology & ToxicologyPreprint
Effects of serotonin agonists LSD and 25CN-NBOH on conditioned place preference and on synaptic plasticity of VTA dopamine neurons in mice
Lauri V. ElsiläiD, Elina I. NagaevaiD, Jari-Pekka Luukkonen, Esa R. KorpiiD
Abstract
The current research on psychedelic compounds such as lysergic amide diethylamide (LSD) is leaning heavily on the notion that psychedelics are not addictive. While much of the literature supports this argument, some of the common use patterns and the descriptions of the subjective effects of these compounds in humans, together with rather lacking and mixed data from non-human animal studies leave room for questions of potentially rewarding or reinforcing stimulus effects. Initiated by a surprising finding in a control study, we investigated these potential rewarding effects of LSD and a selective 5-HT2A agonist 25CN-NBOH using both unbiased and biased designs of conditioned place preference as well as ex vivo patch-clamp electrophysiology measurements of glutamatergic synaptic plasticity on midbrain ventral tegmental area (VTA) dopamine neurons in C57Bl6/J mice. Our results showed no reliable formation of place preference with either compound, agreeing with previous claims of psychedelics having at most weak reinforcing effects. However, we did observe single doses of the drugs, especially LSD, inducing synaptic plasticity in the medially located VTA dopamine neurons, implicating a role for the midbrain dopamine system in the effects of psychedelic drugs. Graphical abstractTreatment with mixed serotonin receptor agonist, psychedelics lysergic acid diethylamide (LSD) or selective serotonin 2A receptor agonist 25CN-NBOH did not cause reliable induction of conditioned place preference in C57Bl/6J mice. However, we did observe single doses of the drugs, especially LSD, inducing synaptic plasticity in the medially located VTA dopamine neurons. These findings challenge some of the previous rodent data but are in general in line with the claims of psychedelics having at most weak reinforcing effects. O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=143 SRC="FIGDIR/small/628157v1_ufig1.gif" ALT="Figure 1"> View larger version (38K): org.highwire.dtl.DTLVardef@57a87org.highwire.dtl.DTLVardef@1af3827org.highwire.dtl.DTLVardef@8fb256org.highwire.dtl.DTLVardef@5504b_HPS_FORMAT_FIGEXP M_FIG C_FIG
- organism: mouse
- assay: electrophysiology
- research focus: cell signaling & trafficking
- approach: experimental assay
- Citations
- 1
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- LSD Restores Synaptic Plasticity in VTA of Morphine-Treated Mice and Disrupts Morphine-Conditioned Place Preference
Michael Von Gunten, Tenna Russell, … Jeffrey G. Edwards·bioRxiv·Jun 12, 2025
- Changes in global brain connectivity in LSD-induced altered states of consciousness are attributable to the 5-HT2A receptor
Katrin H. Preller, Joshua B. Burt, … Alan Anticevic·eLifePeer-reviewed·Oct 25, 2018
- The psychedelic, DOI, increases dopamine release in nucleus accumbens to predictable rewards and reward cues
David Alexander Martin, Angel Delgado, Donna J. Calu·bioRxiv·Mar 29, 2024
- d-Lysergic acid diethylamide has major potential as a cognitive enhancer
Felipe Augusto Cini da Silva, Isis Moraes Ornelas, … Sidarta Tollendal Gomes Ribeiro·bioRxiv·Dec 6, 2019
- Lysergic Acid Diethylamide Alters the Effects of Brain Stimulation in Rodents
Lucas L. Dwiel, Angela M. Henricks, … Wilder T. Doucette·Psychedelic MedicinePeer-reviewed·Feb 28, 2023
- Effect of lysergic acid diethylamide (LSD) on reinforcement learning in humans
Jonathan W. Kanen, Qiang Luo, … Hanneke E.M. den Ouden·Psychological MedicinePeer-reviewed·Nov 22, 2022